Movement Disorders Emergencies Part 1

Robottom, B.; Weiner, William J.; Factor, Stewart A.

doi:10.1001/archneurol.2011.84

Cited by 30 publications

(39 citation statements)

References 40 publications

(28 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Avoid abrupt withdrawal of dopaminergic agents, which can result in malignant hyperthermia (Parkinson's hyperpyrexia), 5 characterised by severe rigidity, fever, altered level of consciousness, and raised creatine kinase concentrations. 20 Close ophthalmological monitoring is needed when starting levodopa in patients with narrow angle glaucoma because of the potential risk of increasing intraocular pressure. 14 Melanoma cases have been reported with the use of levodopa and rasagiline.…”

Section: What Are the Precautions?mentioning

confidence: 99%

Initial drug treatment in Parkinson’s disease:

Muzerengi

Clarke

2015

BMJ

View full text Add to dashboard Cite

Section: What Are the Precautions?mentioning

confidence: 99%

Initial drug treatment in Parkinson’s disease:

Muzerengi

Clarke

2015

BMJ

View full text Add to dashboard Cite

“…This situation typically occurs due to additional medical conditions, as urinary or respiratory infections and metabolic disturbances (hypothyroidism and so on), or even due to a concomitant neurological disease, for example, subdural hematomas, compressive spinal cord lesion or brain tumor 8,10 . Treatment of both de novo and worsening of PD should be focused on resolution of the etiologic process and occasionally symptomatic treatment of parkinsonism using dopaminergic agents 11 .…”

Section: B Parkinsonism-hyperpyrexia and Dyskinesiahyperpyrexia Syndmentioning

confidence: 99%

“…The acute occurrence of psychosis is frequently associated and triggered by the same agents used to treat the motor symptoms of PD (levodopa, dopamine agonists, anticholinergics, amantadine, COMT and MAO-B inhibitors), however other comorbidities, such as infections (urinary and respiratory tract), metabolic or neurological disturbances, may play a role 10,11 . The manifestations typically include visual hallucinations, persecutory delusions, confusion and psychomotor agitation.…”

Section: Acute Psychosis In Parkinson's Diseasementioning

confidence: 99%

See 1 more Smart Citation

Movement disorders emergencies: a review

Munhoz

Moscovich

Araujo

et al. 2012

Arq. Neuro-Psiquiatr.

View full text Add to dashboard Cite

Movement disorders (MD) encompass acute and chronic diseases characterized by involuntary movements and/or loss of control or efficiency in voluntary movements. In this review, we covered situations in which the main manifestations are MDs that pose significant risks for acute morbidity and mortality. The authors examine literature data on the most relevant MD emergencies, including those related to Parkinson's disease, acute drug reactions (acute dystonia, neuroleptic malignant syndrome, serotonergic syndrome and malignant hyperthermia), acute exacerbation of chronic MD (status dystonicus), hemiballism and stiff-person syndrome, highlighting clinical presentation, demographics, diagnosis and management.

show abstract

“…Firstly, there are acute onset movement disorders, typically occurring on drug initiation and less commonly with changes in dose—for example, acute dystonic reactions and neuroleptic malignant syndrome 1. Secondly, there are movement disorders that emerge during drug treatment but stop when the drug is withdrawn2—for example, parkinsonism induced by dopamine receptor blocking drugs (DRBs) or tremor induced by sodium valproate.…”

Section: Introductionmentioning

confidence: 99%